Page last updated: 2024-10-25

ci 994 and Osteolysis

ci 994 has been researched along with Osteolysis in 1 studies

tacedinaline: oral cytostatic drug with impressive differential activity against leukemic cells & normal stem-cells
tacedinaline : A benzamide obtained by formal condensation of the carboxy group of 4-acetamidobenzoic acid with one of the amino groups of 1,2-phenylenediamine. An oral cytostatic drug with impressive differential activity against leukemic cells and normal stem-cells. Also used in combination therapy for selected tumors including non-smoll cell lung, pancreatic, breast, and colorectal cancers.

Osteolysis: Dissolution of bone that particularly involves the removal or loss of calcium.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guo, D1
Hong, D1
Wang, P1
Wang, J1
Chen, L1
Zhao, W1
Zhang, L1
Yao, C1
Chu, B1
Chen, S1
Li, Z1
Chen, H1

Other Studies

1 other study available for ci 994 and Osteolysis

ArticleYear
Histone deacetylase inhibitor CI-994 inhibits osteoclastogenesis via suppressing NF-κB and the downstream c-Fos/NFATc1 signaling pathways.
    European journal of pharmacology, 2019, Apr-05, Volume: 848

    Topics: Animals; Benzamides; Cell Differentiation; Cells, Cultured; Dose-Response Relationship, Drug; Histon

2019